Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00325728. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of 8 Week Treatment of Rozerem 8 mg (QHS) in Sleep Disturbed, Mild to Moderately Severe Alzheimer's Disease Subjects
Study identification
- NCT ID
- NCT00325728
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Ramelteon Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2006
- Primary completion
- Jul 31, 2007
- Completion
- Aug 19, 2007
- Last update posted
- Aug 13, 2017
2006 – 2007
United States locations
- U.S. sites
- 72
- U.S. states
- 26
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alabaster | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Sun City | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Oxnard | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | San Francisco | California | — | — |
| Not listed | Darien | Connecticut | — | — |
| Not listed | Waterbury | Connecticut | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Brooksville | Florida | — | — |
| Not listed | Deerfield Beach | Florida | — | — |
| Not listed | Fort Myers | Florida | — | — |
| Not listed | Hallandale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Largo | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Naples | Florida | — | — |
| Not listed | Orange City | Florida | — | — |
| Not listed | Pompano Beach | Florida | — | — |
| Not listed | Port Charlotte | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | Sunrise | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Savannah | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | West Yarmouth | Massachusetts | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Dover | New Hampshire | — | — |
| Not listed | Piscataway | New Jersey | — | — |
| Not listed | Princeton | New Jersey | — | — |
| Not listed | Stratford | New Jersey | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Whiting | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | New Hyde Park | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Havertown | Pennsylvania | — | — |
| Not listed | Jenkintown | Pennsylvania | — | — |
| Not listed | Moon Township | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Beaufort | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | North Charleston | South Carolina | — | — |
| Not listed | Bellaire | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Wichita Falls | Texas | — | — |
| Not listed | Bennington | Vermont | — | — |
| Not listed | Burlington | Vermont | — | — |
| Not listed | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00325728, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2017 · Synced Apr 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00325728 live on ClinicalTrials.gov.